Edwards Lifesciences Corp
EW- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001099800
In the last 90 days, Edwards Lifesciences Corp insiders filed 0 open-market purchases and 10 sales; 1,344 institutions reported holding it in 13F filings for Q2 2026, worth $47.2B in total; no superinvestor holds it.
Holders of 5% or more of EW
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Edwards Lifesciences Corp, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 7.50%44.3M shares | – | Oct 17, 20251 filing | Oct 17, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Edwards Lifesciences Corp, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 20266:04 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −11.72 ppfrom 11.72%Below 5% | Mar 13, 2026 | SEC |
| Oct 17, 20256:05 PM ET | BlackRock, Inc. | 13G/A | 7.50%44.3M shares | – | Sep 30, 2025 | SEC |
| Aug 12, 202510:34 AM ET | Wellington Management Group LLPand 2 others | 13G/A | 3.40%19.8M shares | –Below 5% | Jun 30, 2025 | SEC |
| Jan 30, 20259:34 PM ET | Vanguard Group Inc | 13G/A | 11.72%69.1M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Edwards Lifesciences Corp shares.
No Form 144 notices for Edwards Lifesciences Corp are on file.